Results

Total Results: 1,544 records

Showing results for "drug".

361. Antipsychotics-Adults Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
     August 01, 2012 - Food and Drug Administration (FDA). … contrast to previous reviews, this CER focuses on comparisons of individual medications rather than drug … • Drug dosage. • Followup period. … National Library of Medicine’s TOXLINE® and the MedEffect™ Canada Adverse Drug Reaction Database. … In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.

362. Diagnosis and Management of Gout: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
     January 01, 2017 - overall adverse events ��� Subgroup of 1 RCT 2269 Age and race do not affect the efficacy of either drug … include toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), bone marrow suppression, and drug

363. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
     September 27, 2012 - Tumor ischemia raises the drug concentration, extends the retention of the chemotherapeutic agent, … most of their blood supply via the hepatic artery and the high first- passage effect (a phenomenon of drug … doxorubicin into the tumor, allowing a longer intratumoral exposure and less systemic exposure to the drug … "Chemoembolization, Therapeutic"[Mesh] OR "Radiotherapy"[Mesh] OR "radiotherapy "[Subheading] OR "drug … Food and Drug Administration Web site, and relevant conference abstracts (from conferences identified

364. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
     January 01, 2012 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug

365. Psoriasis-Chronic Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
     November 01, 2012 - etanercept, and adalimumab), and one anti-IL 12/23 agent (ustekinumab) have approval from the Food and Drug … agents concluded a difference in efficacy, suggesting heterogeneity within the class and indicating drug … and therefore do not make between-class comparisons, rather limit comparisons with the individual drug … systemic biologic agents and systemic nonbiologic agents (between-class comparisons on an individual drug … systemic biologic agents and systemic nonbiologic agents (between-class comparisons on an individual drug

366. AHRQ Evidence-Based Practice Center (EPC) Program Research Gaps Summary: Pain Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
     January 01, 2023 - long-term treatment duration, and make direct comparisons among key interventions both within and across drug … • Studies on the effects of risk mitigation strategies (use of naloxone, urine drug screening, prescription … drug monitoring programs, and abuse deterrent formulations) on clinical outcomes

367. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
     June 01, 2022 - Systematic Reviews, PsycINFO®, and Scopus from July 2020 to September 2021.We also searched Food and Drug … From the previous report, NSAIDs as a drug class, compared with placebo, resolved pain at 2 hours … Therapy] 24 exp Vomiting/dt [Drug Therapy] 25 (((drug* or agent* or medication*) adj3 (nausea or … Study to assess adverse events and drug to drug interaction of oral tablet atogepant http://dx.doi.org … Clin Drug Investig. 2021 Feb;41(2):119-32. doi: 10.1007/s40261-020- 00997-1. PMID: 33426614.

368. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Recent marketing data collected by the FDA’s Center for Drug Evaluation and Research indicates that … The drug potentially holds additional promise as an AUD therapy because its safety profile is better … Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. … Mobile medical applications: guidance for industry and Food and Drug Administration staff. … Food and Drug Administration (FDA); 2015 Feb 9. 44 p.

369. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
     July 13, 2011 - , continuation phase) or recurrence (i.e., maintenance phase) when a patient 1) continues the drug … medications with new formulations (such as an extended release formulation) are approved by the Food and Drug … Administration (FDA) through an application called a supplemental new drug application (sNDA). … interest is whether response or remission can be maintained if patients who have responded to one drug … If fewer than three head-to-head trials are available for any drug comparison, we will compute indirect

370. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
     January 01, 2010 - Misclassification of drug metabolizer status, along with the possibility that it might result in excessive … or inadequate dosing, and selection of alternate drug that proves to be less effective or to have more

371. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
     April 01, 2022 - Drug Overdose/ 25. or/17-24 26. risk$.ti,ab,kf. A-4 27. … Drug Overdose/ 27. or/17-26 28. Substance Abuse Detection/ 29. … Drug Overdose/ 25. or/17-24 26. risk$.ti,ab,kf. 27. … Drug Overdose/ 27. or/17-26 28. Substance Abuse Detection/ 29. … Measures of diagnostic accuracy • Intermediate outcomes (e.g., pharmacokinetics/pharmacodynamics, drug-drug

372. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
     December 04, 2015 - Trends in antipsychotic drug use by very young, privately insured children. … Drug Safety. 2011 Aug 1;34(8):651-68. PMID: 21751826. 17. … CNS Neuro Dis Drug Tar. 2010 Mar;9(1):50-4. PMID: 20201815. 29. … Drug! FDA!status! Indications! Age!group!approved!for! Black!box!Warnings! … $drug$therapy.fs.$ !

373. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0399_01-07-2011.pdf
     January 01, 2011 - brachytherapy, RE; D) liver-directed chemotherapy, including hepatic artery infusion (HAI) chemotherapy, TACE, drug-eluting … brachytherapy, RE; D) liver-directed chemotherapy, including hepatic artery infusion (HAI) chemotherapy, TACE, drug-eluting

374. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
     August 01, 2022 - We also searched Food and Drug Administration, ClinicalTrials.gov, Health Canada, the United Kingdom … No change in SOE for NSAIDs as a drug class KQ 2. NSAIDs: Dexketoprofen trometamol vs. … No change in SOE for NSAIDs as a drug class KQ 2. Antiemetic: Magnesium sulfate vs. … Therapy] 24 exp Vomiting/dt [Drug Therapy] 25 (((drug* or agent* or medication*) adj3 (nausea … Study to assess adverse events and drug to drug interaction of oral tablet atogepant and ubrogepant

375. EHC Protocol: Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-protocol.pdf
     September 24, 2024 - evidence to recommend metabolic testing.5 In addition to increased fluid intake, ACP recommends empiric drug … Food and Drug Administration (FDA)-approved prescription and over-the-counter medications (Appendix … Food and Drug Administration; HDI = United Nations Development Programme Human Development Index; KQ … OR lumasiran[tw] OR nedosiran[tw] OR penicillamine*[tw] OR sevelamer[tw] OR febuxostat[tw])   Drug … intervention textwords  #11  #9 OR #10  All drug interventions  #12   (“potassium citrate”[

376. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … study examining metadoxine for treating adult ADHD; a similar trial is also planned to study this drug

377. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … spontaneous preterm birth; interventions intended to target both the pregnant woman and fetus (a drug

378. Migraine-Emergency Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
     November 01, 2012 - Food and Drug Administration and that are used, often off label, for acute migraine. … Food and Drug Administration documents related to the drugs of interest were reviewed for additional … The Scientific Resource Center contacted drug manufacturers to request published and unpublished study … to the pain intervention in order to specifically deal with side effects are grouped with the main drug … Instead, we present a summary of drug-related adverse effects by treatment arm that provides an overall

379. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
     November 27, 2012 - We are specific about using the exact drug name for each drug and not using interchangeably. … line 22: three dopamine agonists (pramapexole, ropinirole, and rotigotine) and one anticonvulsant drug … On page 27, the authors say augmentation can occur with long term treatment of drug. … Augmentation can also occur when you first start taking the drug and is reason to change medications … It is an egregious error that gabapentin and gabapentin enacarbil are lumped together as a single drug

380. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1306.pdf
     June 11, 2013 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Results The table below lists two topics for which (1) some human data were available for programs (no drug … Food and Drug Administration (FDA) ruled recently that this intervention is not subject to FDA approval … Food and Drug Administration stated it would not intervene to require regulation of the machine.7 On … Obama administration drops its appeal of Plan B ruling, will widen access to drug.